Income Statement

v3.19.1
Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Revenues $ 2,500 $ 2,500
Operating expenses:    
Research and development expenses 1,514,463 1,169,441
General and administrative expenses 944,602 1,182,054
Total operating expenses 2,459,065 2,351,495
Operating loss (2,456,565) (2,348,995)
Other income (expense):    
Interest income 29,000 17,749
Interest expense (2,017) (1,920)
Change in fair value of derivative instruments (340,115) 190,219
Other income (expense) (344,295) (4,021)
Total other income (expense) (657,427) 202,027
Net loss $ (3,113,992) $ (2,146,968)
Net loss per share - basic and diluted (in dollars per share) $ (0.17) $ (0.14)
Weighted average common shares outstanding - basic (in shares) 18,216,421 15,116,937
Comprehensive loss:    
Net loss $ (3,113,992) $ (2,146,968)
Foreign currency translation adjustment (1,743) 115
Comprehensive loss $ (3,115,735) $ (2,146,853)

Source